Serum level of Vitamin D is associated with COVID‑19 mortality rate in hospitalized patients

Background: Due to widespread of coronavirus disease 2019 (COVID‑19) infection, identification of its risk factors and clinical characteristics are important. The aim of the present study was to assess Vitamin D levels in individuals with severe acute respiratory syndrome coronavirus‑19 infection and to report on its potential as a predictive marker. Materials and Methods: All patients, diagnosed with COVID‑19 infection from February 16 to March 21, 2020, and referred to Firoozgar Hospital, Tehran, Iran, were enrolled in this study. Vitamin D analysis was undertaken on patient serum samples using a commercial kit (Pars Azmoon Co., Tehran, Iran). SPSS v. 22 was used for statistical analysis. Results: Vitamin D serum concentration was analyzed in a total of 317 patients whose mean age ± standard deviation was 62.05 ± 15 years and with 62.5% being male. A significant association of Vitamin D level and death was observed. Higher levels of serum Vitamin D had protection against death (odds ratio = 0.955 [95% confidence interval = 0.923–0.988], P = 0.008). Conclusion: As a preliminary study in the Iranian population who suffered COVID‑19 disease, we identified that Vitamin D deficiency was associated with a higher death rate and intensive care unit admission.